News + Filings Transactions
|
MCLAUGHLIN JOHN PETER
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/25/2023 | LENSAR, Inc. | | Grant | Common Stock | 9.3k | $0.00 | $0 | | 05/25/2023 |
| 05/25/2023 | LENSAR, Inc. | | Grant | Stock Option (Right to Buy) | 33.2k | $3.23 | $107.2k | | 05/25/2023 |
| 05/25/2022 | LENSAR, Inc. | | Grant | Common Stock | 4.3k | $0.00 | $0 | | 05/25/2022 |
| 05/25/2022 | LENSAR, Inc. | | Grant | Stock Option (Right to Buy) | 15.6k | $7.00 | $109.3k | | 05/25/2022 |
| 06/17/2021 | ROCKWELL MEDICAL, INC. | RMTI | Grant | Stock Option (Right to Buy) | 72.9k | $0.90 | $65.6k | | 06/17/2021 |
| 06/17/2021 | ROCKWELL MEDICAL, INC. | RMTI | Grant | Common Stock | 50k | $0.00 | $0 | | 06/17/2021 |
| 05/18/2021 | LENSAR, Inc. | | Grant | Stock Option (Right to Buy) | 20.8k | $7.49 | $156.1k | | 05/18/2021 |
| 03/12/2021 | LENSAR, Inc. | | Grant | Stock Option (Right to Buy) | 13.4k | $8.62 | $115.9k | | 03/12/2021 |
| 02/01/2021 | LENSAR, Inc. | | Grant | Stock Option (Right to Buy) | 28.2k | $7.08 | $200k | | 02/01/2021 |
| 12/22/2020 | PDL BIOPHARMA, INC. | PDLI | Sale | Common stock | 277.9k | $2.61 | $724.6k | | 12/21/2020 |
| 12/21/2020 | PDL BIOPHARMA, INC. | PDLI | Sale | Common stock | 50k | $2.62 | $131.2k | | 12/21/2020 |
| 08/19/2020 | PDL BIOPHARMA, INC. | PDLI | Grant | Stock Option (right to buy) | 118.7k | $3.63 | $430.8k | | 08/19/2020 |
| 08/19/2020 | PDL BIOPHARMA, INC. | PDLI | Grant | Common stock | 25.8k | $0.00 | $0 | | 08/19/2020 |
| 05/18/2020 | ROCKWELL MEDICAL, INC. | RMTI | Grant | Stock Option (Right to Buy) | 34k | $2.04 | $69.4k | | 05/18/2020 |
| 05/18/2020 | ROCKWELL MEDICAL, INC. | RMTI | Grant | Common Stock | 51.8k | $0.00 | $0 | | 05/18/2020 |
| 01/29/2020 | ROCKWELL MEDICAL, INC. | RMTI | Grant | Common Stock | 12.6k | $0.00 | $0 | | 01/29/2020 |
| 09/05/2019 | ROCKWELL MEDICAL, INC. | RMTI | Grant | Common Stock | 22.6k | $0.00 | $0 | | 09/05/2019 |
| 09/05/2019 | ROCKWELL MEDICAL, INC. | RMTI | Grant | Stock Option (Right to Buy) | 28.4k | $2.56 | $72.6k | | 09/05/2019 |
| 06/20/2019 | PDL BIOPHARMA, INC. | PDLI | Grant | Stock Option (right to buy) | 126k | $3.00 | $378.2k | | 06/20/2019 |
| 12/31/2018 | PDL BIOPHARMA, INC. | PDLI | Disposition | Common stock | 123.4k | $0.00 | $0 | | 12/31/2018 |
| 12/27/2018 | PDL BIOPHARMA, INC. | PDLI | Disposition | Common stock | 627.2k | $0.00 | $0 | | 12/27/2018 |
| 06/08/2018 | PDL BIOPHARMA, INC. | PDLI | Grant | Stock Option (right to buy) | 1.9M | $2.94 | $5.7M | | 06/08/2018 |
| 12/15/2017 | PDL BIOPHARMA, INC. | PDLI | Disposition | Common stock | 151.7k | $0.00 | $0 | | 12/15/2017 |
| 12/13/2016 | PDL BIOPHARMA, INC. | PDLI | Disposition | Common stock | 5.2k | $0.00 | $0 | | 12/13/2016 |
| 05/20/2016 | Seagen Inc. | SGEN | Grant | | 3.7k | $0.00 | $0 | | 05/20/2016 |
| 05/20/2016 | Seagen Inc. | SGEN | Grant | Non-Qualified Stock Option (right to buy) | 9.3k | $38.82 | $359.5k | | 05/20/2016 |
| 05/23/2011 | PDL BIOPHARMA, INC. | PDLI | Grant | Common Stock | 30.5k | $0.00 | $0 | | 05/23/2011 |
|